Cancer trial halted: experimental combo shows promise but stops short
NCT ID NCT05846646
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 37 times
Summary
This study tested whether adding an experimental drug (IMSA101) to standard immunotherapy and a special type of radiation (PULSAR) could help control cancer in people with non-small cell lung cancer or kidney cancer that had spread to a few places. Only 6 people enrolled before the trial was stopped early. The goal was to see if the combination slowed cancer growth and was safe.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OLIGOMETASTATIC DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Baylor College of Medicine Medical Center
Houston, Texas, 77030, United States
-
City of Hope Orange County Lennar Foundation Cancer Center
Irvine, California, 92618, United States
-
Huntsman Cancer Institute, University of Utah
Salt Lake City, Utah, 84112, United States
-
Laura & Isaac Perlmutter Cancer Center at NYU Langone Health
New York, New York, 10016, United States
-
Louis Stokes Cleveland VA Medical Center
Cleveland, Ohio, 44106, United States
-
MetroHealth Medical Center
Cleveland, Ohio, 44109, United States
-
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, 08903, United States
-
The University of Kansas Medical Center
Kansas City, Kansas, 66160, United States
-
University of Wisconsin Hospital and Clinics
Madison, Wisconsin, 53792, United States
Conditions
Explore the condition pages connected to this study.